0001209191-20-037962.txt : 20200619 0001209191-20-037962.hdr.sgml : 20200619 20200619164416 ACCESSION NUMBER: 0001209191-20-037962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200617 FILED AS OF DATE: 20200619 DATE AS OF CHANGE: 20200619 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simeonidis Simos CENTRAL INDEX KEY: 0001778545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 20976206 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS STREET 2: 10628 SCIENCE CENTER DR., STE. 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-17 0 0001505512 Regulus Therapeutics Inc. RGLS 0001778545 Simeonidis Simos C/O REGULUS THERAPEUTICS 10628 SCIENCE CENTER DR. #225 SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 0.88 2020-06-17 4 A 0 23250 0.00 A 2030-06-16 Common Stock 23250 23250 D Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service. Christopher Aker, Attorney in Fact 2020-06-19